US Vitamin B9 Prices Up 2.6% on Strategic Supplier Moves in Early December 2025

US Vitamin B9 Prices Up 2.6% on Strategic Supplier Moves in Early December 2025

Thomas Mann 12-Dec-2025

The market value of Vitamin B9 in the U.S. market has observed a bullish tone in early December 2025. The increase in the prices was driven by assertive supplier actions and a demand environment that was firm. The market participants of Vitamin B9 has observed that domestic suppliers have capitalized on rapidly rising prices in the Chinese market which is a key export reference for global procurement. The deliberate upward adjustment of the Vitamin B9 prices was aligned with a period when downstream manufacturers have prioritized uninterrupted production schedules and strengthened inventory positions for their nutritional, pharmaceutical and food-grade formulations. The U.S. market of Vitamin B9 has displayed an unusually strong pricing environment as buyers were ready to absorb higher costs to secure consistent supply. The confidence of buyers with the responsive supplier strategies have reflected global sentiment and reinforced the U.S. market’s influential role in determining short-term value expectations.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Vitamin B9

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.